Related Experiment Video

Updated: Jun 28, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:38

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

63

Prostaglandin E-induced polycyclic cutaneous eruption with geometric features

Ananya Shah1, Jinia El-Feghaly1, Alexandra M Bender1

  • 1Department of Dermatology, University of Rochester, Rochester, New York, USA.

Pediatric Dermatology
|April 18, 2024
PubMed

Insights

Prostaglandin E1 (PGE1) is crucial for infants with congenital heart disease (CHD). A case study shows a rash from PGE1 can resolve with reduced dosage, potentially allowing continued treatment.

Area of Science:

  • Neonatal cardiology
  • Pediatric pharmacology
  • Dermatology

Background:

  • Prostaglandin E1 (PGE1) maintains patency of the ductus arteriosus.
  • PGE1 is vital for ductus-dependent congenital heart disease (CHD) management.
  • Infants with specific CHDs require PGE1 to ensure pulmonary blood flow or proper great artery positioning.

Observation:

  • A neonate receiving PGE1 for CHD developed a distinct rash.
  • The rash presented as bright erythematous annular and polycyclic patches.
  • The dermatological reaction appeared on day 2 of PGE1 administration.

Findings:

  • Reducing the PGE1 dosage led to spontaneous resolution of the rash.
  • The observed rash is a potential side effect of PGE1 treatment.
  • The case suggests PGE1 therapy may not always require interruption due to skin reactions.

Implications:

  • This finding could inform clinical management of PGE1 side effects.
  • It highlights the possibility of continuing essential PGE1 treatment with dosage adjustments.
  • Further investigation into PGE1-induced dermatological reactions in neonates is warranted.

Keywords:
cutaneous drug eruptionneonatepolycyclic

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
Granulocyte-dependent Autoantibody-induced Skin Blistering12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
423
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
166